Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers January 20, 2019
Pharmacy Choice - June 2017 Newsletter - January 20, 2019

Pharmacy Choice Newsletter - June 2017

Basaglar® is newer biosimilar insulin glargine product which is starting to replace Lantus® insulin on several prescription plan formularies in 2017. Basaglar® is the first "follow-on" biosimilar insulin product approved by the FDA the…
June Disease Focus
Focus on Pharmacotherapy for Depression
Each year approximately 21 million Americans suffer a major depressive episode, or about 16% of the population. The lifetime prevalence of depression in women is 10-25% and 5-12% for men. First-degree relatives of patients with depression are 1.5-3 times more likely to develop depression. Unfortunately, up to 15% of depressed patients will attempt suicide; thus, prompt recognition and effective treatment for depression is critical. In addition to suicidal ideation…
Featured Company
Essilor–the world's leading ophthalmic optics company is hiring
Essilor of America, Inc. (Essilor), is the leading manufacturer and wholesaler of prescription lenses in the United States. Improving lives by improving sight isn't just a commitment to the world around us – we're always looking for new ways to encourage the pursuits and personal visions of our employees.
What does this mean for you? It means that Essilor is a place where you can bring your vision to life and where your energy and imagination can create real impact. When you work each day to help correct, protect and support the world's vision, it's a point of pride. A chance to better the globe – and yourself.
Hot Jobs
Retail & Hospital Opportunities Nationwide
Pharmacy Healthcare Solutions
Clinical Staff Pharmacist
Sugarland, TX
Inpatient-Clinical Pharmacist
Cameron and Company, Inc
Seattle, WA
Pharmacist - Acute - (Pharma / Pharm)
Club Staffing
New Haven, CT
Rx Career Center logo
Quick Poll
How likely would you be to recommend Basaglar® as an alternative to Lantus®?
• Very likely
• Somewhat likely
• Neutral / no opinion yet
• Somewhat unlikely
• Very unlikely
Last Month's Poll
How likely would you be to recommend safinamide for a patient with Parkinson's disease on levodopa/carbidopa with significant "off" periods?
Very likely - 10.5%
Somewhat likely - 36.8%
Neutral/no opinion yet - 36.8%
Somewhat unlikely - 10.5%
Very unlikely - 5.2%
Continuing Education for Pharmacy Professionals
RxSchool logo Enroll now at for the latest online Live and Enduring Continuing Education.
Live On-line Webinars
Vitamin D Primer for Pharmacy Professionals
Tue, June 13 - 7:00–9:00pm/et
Darrell Hulisz, RPh, PharmD
NEW! Telepharmacy- Remote Delivery of Pharmacy Services
Wed, June 14 - 8:00–10:00pm/et
Ken Baker, RPH
NEW! Identification and Resolution of Clinically Relevant Drug-Drug Interactions in Adults
Thu, June 15 - 8:00–10:00pm/et
Joseph Vande Griend, BCPS, CGP, PharmD
Check out our LIVE CE Calendar for additional programs
Featured Distance CE Courses
Explore our Distance CE Course Catalog for additional courses
Copyright © 2017 Pharmacy Choice - All rights reserved.
Previous Newsletters
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
June 2017
May 2017
April 2017
March 2017
February 2017

Be seen by thousands of industry eyes.
Advertise in the Pharmacy Choice Newsletter.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement